Altamira Therapeutics Ltd.
CYTO
$1.64
$0.021.24%
Headlines
5/1/2024
-
The Fly
5/1/2024
-
Globe Newswire
4/24/2024
-
The Fly
4/24/2024
-
Globe Newswire
4/17/2024
-
Globe Newswire
4/16/2024
-
TipRanks Financial Blog
4/15/2024
-
Globe Newswire
4/12/2024
-
Ticker Report
4/12/2024
-
Insider Monkey
4/11/2024
-
GuruFocus
4/10/2024
-
SeekingAlpha
4/10/2024
-
Seeking Alpha: Transcripts
4/10/2024
-
SeekingAlpha
4/10/2024
-
The Fly
4/10/2024
-
The Fly
4/10/2024
-
Globe Newswire
4/4/2024
-
Globe Newswire
3/25/2024
-
The Fly
3/25/2024
-
Globe Newswire
3/4/2024
-
Seeking Alpha - Healthcare
3/4/2024
-
SeekingAlpha.com: All News
2/7/2024
-
Globe Newswire
2/3/2024
-
Ticker Report
Filings
Wednesday, April 10, 2024
Sunday, December 31, 2023
Week of Aug 19 and 23 (est)
Price History
Business Description
Altamira Therapeutics Ltd. operates as a preclinical-stage biopharmaceutical company in Switzerland and Australia. The company develops and supplies OligoPhore/SemaPhore platforms, which are...
more